|
||||
|
DeVry Inc. Adopts Shareholder Rights Plan
November 24, 2004 08:00 AM US Eastern Timezone
DeVry Inc. Adopts Shareholder Rights Plan OAKBROOK TERRACE, Ill.--(BUSINESS WIRE)--Nov. 24, 2004--DeVry Inc. (NYSE Subject to certain exceptions, the Rights will be exercisable only if a person or group acquires 15% or more of DeVry Inc. Common Stock or announces a tender or exchange offer which would result in ownership of 15% or more of the Common Stock. Each Right, which is not presently exercisable and is represented by the Company's Common Stock certificates, will entitle its holder to buy one one-thousandth of a share of Common Stock at an exercise price of $75 subject to adjustment. Following the acquisition of 15% or more of DeVry Inc. Common Stock by a person or group, the holders of the Rights (other than the acquiring person or group) will be entitled to purchase shares of Common Stock at half-price, and, in the event of a subsequent merger or other acquisition of the Company, to buy shares of common stock of the acquiring entity at one-half of the market price of those shares. The Rights are redeemable for $.001 per Right, subject to adjustment, before the acquisition by a person or group of 15% or more of the Company's Common Stock. The Rights will expire on December 6, 2014. Further details concerning the Rights Plan are contained in a letter that will be mailed to all DeVry Inc. shareholders after the record date. DeVry has received an oral inquiry about the possibility of a business combination with the Company on unspecified terms. In addition, DeVry believes that the current market price of its stock is low compared to the value of the Company. The DeVry board believes that the plan will help to protect shareholders against abusive takeover tactics such as two-tier or partial tender offers, open market accumulations and other tactics that may be used to gain control of a company without paying a fair price to all shareholders. The plan is designed to assure that shareholders are not deprived of their rights to share fully in the Company's long-term potential, but not to prevent a fairly valued bid for the Company. While the Company's share price has recently been depressed, the Company has implemented plans to improve its recruitment of full-time campus based students and to return to previous levels of financial return. This shareholder rights plan allows the outcome of these operational and managerial changes to be realized without short-term pressure to respond to inadequate proposals. DeVry Inc. (NYSE Certain information contained in this release may constitute forward-looking statements pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995. Such statements may involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Potential risks and uncertainties include, but are not limited to, market conditions, dependence on student financial aid, state and provincial approval and licensing requirements, and the other factors detailed in the company's Securities and Exchange Commission filings, including those discussed under the heading "Risk Factors" in the Company's Registration Statement on Form S-3 (No. 333-22457) filed with the SEC. Contacts DeVry Inc. Marilynn Cason (Investors), 630-574-1901 or Dresner Corporate Services John Kroen (Media), 312-726-3600
__________________
Moderator - State Licensing Forum Still skeptical after all these years. This is it. There are no hidden meanings.WYSIWYG http://www.internetmedicalschool.homestead.com http://www.chiropractormds.homestead.com/index.html |
|
|||
|
elementary version
This article is a bit more elementary for those not so sophisticated in finance. Looks like Ross will be changing partners soon, round and round we go! I told the SGA they should have invested way back when!!
From the Fool: DeVry's the Prize Email this page Motley Fool Take Archive By Rich Smith November 29, 2004 Even if your crystal ball is cracked, you could have seen this one coming. Last month, I penned the following fateful words on the subject of for-profit educator DeVry (NYSE: DV) and its dismal financial performance: "... it appears that the long-heralded consolidation in the for-profit education game may finally be afoot... DeVry's days as an independent company might well be numbered." And indeed, last Wednesday, DeVry announced that an unidentified party was making inquiries "about the possibility of a business combination." Apparently, that's corporate speak for: "We're about to make you an offer you can't refuse." For no sooner had the suggestion been made than DeVry jumped into full-scale panic mode, announcing a "shareholder rights plan," also often referred to as a "poison pill." The plan calls for a special kind of "rights dividend" to be distributed to shareholders on December 6, the rights to which kick in when a would-be acquirer of the company attains at least 15% of its outstanding shares. At that point, shareholders can exercise their rights by purchasing one share of DeVry common stock at half the then-current market price (DeVry would issue new shares to settle the purchases). The effect is to increase the number of DeVry shares that a would-be acquirer must buy to get a controlling stake in the company. DeVry's shares jumped nearly 19% in response to the company's press release. But that was due more to the news that someone wants to buy the shares -- presumably at a premium -- than to enthusiasm for the poison pill. Such so-called shareholder rights plans would be much more aptly named "management protection plans." If an acquirer can simply bypass management and offer shareholders a good price for their shares, it generally will do so -- giving both the acquirer and the current shareholders what they want, but often leaving management out in the cold. By eating a poison pill, management forces itself back into the discussion. Management can negotiate for a better buyout offer for shareholders, true. But it can also negotiate to keep its jobs after a takeover, for "golden parachutes" for departing executives, and so on. On the other hand, the benefits accruing to shareholders in DeVry's competitors were much more one-sided. In sympathy with DeVry's price rise, shares of peers ITT (NYSE: ESI), Strayer (Nasdaq: STRA), Apollo Group (Nasdaq: APOL), Career Education (Nasdaq: CECO), and Corinthian Colleges (Nasdaq: COCO) also rose in tandem by 3.9% to 5.7%. |
|
||||
|
Re: elementary version
Quote:
__________________
Moderator - State Licensing Forum Still skeptical after all these years. This is it. There are no hidden meanings.WYSIWYG http://www.internetmedicalschool.homestead.com http://www.chiropractormds.homestead.com/index.html |
![]() |
| Thread Tools | |
| Display Modes | |
|
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| DeVry Inc. Provides Update on Workforce Reduction Program | azskeptic | Ross University School of Medicine | 1 | 05-20-2005 09:00 AM |
| ross university count drops 3% after increasing standards | azskeptic | Ross University School of Medicine | 2 | 04-22-2005 08:39 AM |
| DeVry COO Sees Expansion | azskeptic | Ross University School of Medicine | 0 | 12-27-2004 06:55 PM |
| DeVry Inc. Names Steven Riehs Vice President and General Man | azskeptic | Ross University School of Medicine | 0 | 11-12-2004 12:06 PM |
| DeVry buys Ross- Official Press release | Ross Redneck | Ross University School of Medicine | 15 | 03-24-2003 11:09 PM |
International Foreign and Caribbean medical schools,
ValueMD provides information on medical education from premed to residency